BBEU holdings

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 3.47% at a quoted market price (level 1), 21 issuer countries, 1.28% restricted securities.

BBEU's largest investment is ASML Holding NV at 4.15% of net assets. HSBC Holdings Plc and AstraZeneca Plc follow; the three together are 8.67%. Ten companies are 21.57% of the fund; the other 349 share the rest. Among the 721 equity funds measured here, BBEU behaves like 103.8 holdings against a median of 42.4 — 2.5 times the median. Across 27 quarterly filings BBEU has become more concentrated: it behaved like 138.6 at 2019-10-31 and 110.7 at 2026-04-30. Between the 2026-01-31 and 2026-04-30 filings 8 positions were added and 6 dropped; 8.0% of the weight moved. the United Kingdom is the largest country at 21.9% of the portfolio, across 21 countries in the filing.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Between 2019-10-31 and 2026-04-30, BBEU went from behaving like 138.6 equally weighted positions to 110.7 — 20% fewer, while its top ten went from 18.29% to 20.94% of net assets. Read across the funds on the concentration-over-time table.

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

BBEU's filing lists 360 positions including 1.78% of net assets in securities-lending cash collateral. Counted as filed the fund reads 101.1 effective holdings with a top ten of 21.93%; on its own investments — the figure above — it reads 103.8 with a top ten of 21.57%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.

The 15 largest of 359 positions in BBEU's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: BBEU.csv.gz.

Share of BBEU's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

Monthly total returns from Item B.5 of BBEU's own filings, 81 months on record. Not computed here and not from a price feed.

Cross-checked against a series computed separately from prices: median difference 0.17 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: BBEU.json · all funds.

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-07-31, $155m was out to 11 borrowers. The largest, STATE STREET BANK & TRUST COMPANY, held 44.4% of it.

The filing reports no cash collateral position against this loan. Collateral taken in a form the fund does not hold as a position does not appear in N-PORT, so this is silence rather than absence. What the collateral figure can and cannot show. Every quarter BBEU has filed, with each borrower: BBEU.json · all funds.

371 positions became 373: 8 added (2.5% of the fund at the later date), 6 dropped (3.0% at the earlier date). Half the sum of all weight changes, a turnover proxy: 8.0%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of BBEU compared this way, as a feed: changes.xml · all funds: filings received.

New: Roche Holding AG (2.08%), Reckitt Benckiser Group plc (0.30%), Danish Krone (0.04%), CSG NV (0.02%), N/A (0.02%), Norwegian Krone (0.02%). Gone: Roche Holding AG (2.31%), Reckitt Benckiser Group plc (0.41%), Ashtead Group plc (0.20%), JDE Peet's NV (0.04%), N/A (0.01%), N/A (0.01%).

3.5% of BBEU is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.

A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $8.98B. Notional of an interest-rate or currency swap is not equity exposure.

Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of BBEU (103.8). Same filings, same arithmetic. Position in this list says nothing about which fund is better.